down arrow

Vigil Neuroscience, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92673K1088
USD
8.05
0.00 (0.00%)

Aug 06

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

1.318.10
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

How big is Vigil Neuroscience, Inc.?

22-Jun-2025

As of Jun 18, Vigil Neuroscience, Inc. has a market capitalization of 368.12 million and reported net sales of 0.00 million with a net profit of -86.73 million over the last four quarters. Shareholder's funds were 71.64 million, and total assets amounted to 117.69 million as of Dec 24.

As of Jun 18, Vigil Neuroscience, Inc. has a market capitalization of 368.12 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -86.73 million during the same period.<BR><BR>As of Dec 24, the shareholder's funds were reported at 71.64 million, and total assets amounted to 117.69 million.

Read More

What does Vigil Neuroscience, Inc. do?

22-Jun-2025

Vigil Neuroscience, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $22 million and a market cap of $368.12 million. Key financial metrics include a negative P/E ratio, no dividend yield, and a return on equity of -133.18%.

Overview:<BR>Vigil Neuroscience, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -22 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 368.12 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -1.32<BR>Return on Equity: -133.18%<BR>Price to Book: 5.65<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Read More

Is Vigil Neuroscience, Inc. technically bullish or bearish?

20-Sep-2025

As of June 9, 2025, Vigil Neuroscience, Inc. has a bullish trend supported by daily moving averages and strong performance, having returned 373.53% year-to-date compared to the S&P 500's 12.22%, although caution is advised due to bearish weekly RSI and Dow Theory signals.

As of 9 June 2025, the technical trend for Vigil Neuroscience, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong indication from the daily moving averages, which are bullish. The weekly MACD and KST also support this bullish outlook, while the monthly MACD remains mildly bullish. However, the weekly RSI is bearish and Dow Theory indicates a bearish stance on both weekly and monthly time frames, which suggests some caution. <BR><BR>In terms of performance, the stock has significantly outperformed the S&P 500 year-to-date with a return of 373.53% compared to the S&P 500's 12.22%. Over the past year, it has also shown a strong return of 117.57% against the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 329 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.60

stock-summary
Return on Equity

-223.40%

stock-summary
Price to Book

7.98

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-27 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
234.02%
0%
234.02%
6 Months
194.87%
0%
194.87%
1 Year
117.57%
0%
117.57%
2 Years
19.79%
0%
19.79%
3 Years
3.87%
0%
3.87%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Vigil Neuroscience, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Vigil Neuroscience, Inc. technically bullish or bearish?

As of 9 June 2025, the technical trend for Vigil Neuroscience, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong indication from the daily moving averages, which are bullish. The weekly MACD and KST also support this bullish outlook, while the monthly MACD remains mildly bullish. However, the weekly RSI is bearish and Dow Theory indicates a bearish stance on both weekly and monthly time frames, which suggests some caution. In terms of performance, the stock has significantly outperformed the S&P 500 year-to-date with a return of 373.53% compared to the S&P 500's 12.22%. Over the past year, it has also shown a strong return of 117.57% against the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-34.96%
EBIT to Interest (avg)
-85.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.32
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
95.37%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.65
EV to EBIT
-3.08
EV to EBITDA
-3.09
EV to Capital Employed
-13.49
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-133.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -25.94% vs -4.95% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-27.40",
          "val2": "-22.40",
          "chgp": "-22.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-26.70",
          "val2": "-21.20",
          "chgp": "-25.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.06% vs -20.94% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-89.20",
          "val2": "-88.50",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-84.30",
          "val2": "-82.60",
          "chgp": "-2.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-27.40
-22.40
-22.32%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-26.70
-21.20
-25.94%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -25.94% vs -4.95% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-89.20
-88.50
-0.79%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-84.30
-82.60
-2.06%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -2.06% vs -20.94% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Vigil Neuroscience, Inc. stock-summary
stock-summary
Vigil Neuroscience, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."